The aim of this study was to establish an early prediction model of adverse outcomes of PDA (PDAao) by echocardiographic parameters and NT-proBNP levels and to predict the possibility of PDAao in VLBW infants to provide references for early clinical intervention in PDA. This evidence concerns the gene NPPB and Patent ductus arteriosus.